SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004440
Filing Date
2018-05-09
Accepted
2018-05-09 13:09:56
Documents
71
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20180331x10q.htm 10-Q 1710232
2 EX-31.1 clvs-20180331ex31158d734.htm EX-31.1 19872
3 EX-31.2 clvs-20180331ex31264d9e2.htm EX-31.2 20106
4 EX-32.1 clvs-20180331ex321b98813.htm EX-32.1 7986
5 EX-32.2 clvs-20180331ex322ff0424.htm EX-32.2 8367
  Complete submission text file 0001558370-18-004440.txt   7260047

Data Files

Seq Description Document Type Size
6 EX-101.INS clvs-20180331.xml EX-101.INS 1726299
7 EX-101.SCH clvs-20180331.xsd EX-101.SCH 44126
8 EX-101.CAL clvs-20180331_cal.xml EX-101.CAL 60053
9 EX-101.DEF clvs-20180331_def.xml EX-101.DEF 158939
10 EX-101.LAB clvs-20180331_lab.xml EX-101.LAB 458339
11 EX-101.PRE clvs-20180331_pre.xml EX-101.PRE 323130
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 18817588
SIC: 2834 Pharmaceutical Preparations